Package Leaflet: Information for the User
Aproxxamlo 150 mg/5 mg film-coated tablets
Aproxxamlo 150 mg/10 mg film-coated tablets
Aproxxamlo 300 mg/5 mg film-coated tablets
Aproxxamlo 300 mg/10 mg film-coated tablets
irbesartan/amlodipine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Aproxxamlo
Aproxxamlo contains two active substances: irbesartan and amlodipine.
What is Aproxxamlo used for
Aproxxamlo is used to treat high blood pressure in adult patients who are already taking irbesartan and amlodipine as separate tablets.
How Aproxxamlo works
Irbesartanbelongs to a group of medicines known as “angiotensin-II receptor antagonists”. Angiotensin-II is a substance produced in the body that causes blood vessels to constrict, leading to an increase in blood pressure. Irbesartan works by blocking the effect of angiotensin-II, relaxing blood vessels and lowering blood pressure.
Amlodipinebelongs to a group of medicines known as “calcium channel blockers”. Amlodipine prevents calcium from entering the blood vessel walls, which makes the blood vessels relax and lowers blood pressure.
This means that both active substances help prevent blood vessels from constricting. As a result, blood vessels relax and blood pressure decreases.
Do not take Aproxxamlo
Warnings and precautions
Consult your doctor before taking Aproxxamlo if you have any of the following conditions:
Your doctor may check your kidney function, blood pressure, and blood electrolyte levels (such as potassium) at regular intervals.
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Aproxxamlo. Your doctor will decide whether to continue treatment. Do not stop taking Aproxxamlo on your own.
If you are pregnant or think you may be pregnant, inform your doctor. Aproxxamlo is not recommended during pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to your baby (see “Pregnancy and breast-feeding” in section 2).
See also the information in “Do not take Aproxxamlo” in section 2.
Children and adolescents
This medicine must not be used in children and adolescents under 18 years of age, as the safety and efficacy have not been fully established.
Other medicines and Aproxxamlo
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Aproxxamlo may affect or be affected by other medicines, such as:
Taking Aproxxamlo with food and drinks
Aproxxamlo can be taken with or without food.
People taking Aproxxamlo must not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice can lead to an increase in the levels of the active ingredient amlodipine in the blood, which can cause an unpredictable reduction in blood pressure.
Pregnancy and breast-feeding
Pregnancy
Do not take Aproxxamlo if you are pregnant.
You should inform your doctor if you think you may be pregnant or are planning to become pregnant. Your doctor will normally advise you to stop taking Aproxxamlo and will recommend that you take another medicine to lower your blood pressure instead. Aproxxamlo is not recommended during the first trimester of pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to your baby.
If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Breast-feeding
Tell your doctor if you are about to start or are already breast-feeding, as Aproxxamlo is not recommended for use during breast-feeding. Your doctor will normally advise you to stop taking Aproxxamlo and will recommend that you take another medicine to lower your blood pressure instead, especially if your baby is newborn or premature.
Driving and using machines
Aproxxamlo may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy, tired, or give you a headache, do not drive or use machines and consult your doctor immediately.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
Your doctor will decide the appropriate dose of Aproxxamlo depending on your condition and whether you are taking other medicines.
It is important to continue taking Aproxxamlo for as long as your doctor prescribes it to maintain precise control of your blood pressure.
Method of administration
Aproxxamlo is taken orally.
The recommended dose is one tablet once daily. You should try to take your daily dose at the same time each day.
The tablets should be swallowed with a sufficient amount of liquid, such as a glass of water. Do not take Aproxxamlo with grapefruit or grapefruit juice.
Aproxxamlo can be taken with or without food.
Use in children and adolescents
Aproxxamlo must not be given to children and adolescents under 18 years of age.
If you take more Aproxxamlo than you should
If you accidentally take too many tablets, contact your doctor immediately or call the Toxicology Information Service, telephone: 91 562 04 20, stating the medicine and the amount taken. The symptoms of overdose are low blood pressure, increased heart rate, and possible decreased heart rate.
Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing that can develop up to 24-48 hours after ingestion.
If you forget to take Aproxxamlo
If you accidentally miss a dose, simply take your normal dose when it is due next. Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop taking Aproxxamlo and contact your doctor immediately or go to the casualty department of your nearest hospital if you experience any of the following serious side effects:
Other side effects
The following side effects have been reported with irbesartan and/or amlodipine:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Not known(frequency cannot be estimated from the available data)
If any of the above side effects affect you severely, inform your doctor.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Aproxxamlo Composition
The active ingredients are irbesartan and amlodipine.
Product Appearance and Packaging Content
The film-coated Aproxxamlo 150 mg/5 mg tablets are white, oval-shaped, and marked with "150/5" on one side.
The film-coated Aproxxamlo 150 mg/10 mg tablets are pink, oval-shaped, and marked with "150/10" on one side.
The film-coated Aproxxamlo 300 mg/5 mg tablets are yellow, oval-shaped, and marked with "300/5" on one side.
The film-coated Aproxxamlo 300 mg/10 mg tablets are white, oval-shaped, and scored on one side.
Aproxxamlo tablets are available in blister packs of 15, 28, 30, 90, and 98 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
sanofi-aventis, S.A.
C/ Rosselló i Porcel, 21
08016 Barcelona
Spain
Manufacturer
S.C. Zentiva, S.A.
B-dul Theodor Pallady nr. 50, sector 3
Cod 032266 Bucharest
Romania
or
Sanofi Winthrop Industrie
30-36 Avenue Gustave Eiffel
37100 - Tours
France
This medicinal product is authorized in the Member States of the European Economic Area under the following names
Spain: APROXXAMLO 150 mg/5 mg film-coated tablets; APROXXAMLO 150 mg/10 mg film-coated tablets; APROXXAMLO 300 mg/5 mg film-coated tablets; APROXXAMLO 300 mg/10 mg film-coated tablets
Greece, Italy, Portugal: APROXXAMLO
Belgium, Luxembourg: Aprexevo 150 mg/5 mg film-coated tablets - pellicule-coated tablets - Filmtabletten; Aprexevo 150 mg/10 mg film-coated tablets - pellicule-coated tablets - Filmtabletten; Aprexevo 300 mg/5 mg film-coated tablets - pellicule-coated tablets - Filmtabletten; Aprexevo 300 mg/10 mg film-coated tablets - pellicule-coated tablets - Filmtabletten
France, Romania: APREXEVO
Date of the last revision of this leaflet: December 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of APROXXAMLO 150 MG/10 MG FILM-COATED TABLETS in October, 2025 is around 9.71 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.